The market dynamics of the intracranial pressure monitoring (ICP) market exhibit a complex interplay of factors shaping its growth and evolution. At its core, the demand for ICP monitoring is driven by the rising incidence of traumatic brain injuries, strokes, and neurological disorders, coupled with an aging population susceptible to such conditions. As healthcare systems worldwide prioritize the improvement of patient outcomes and the reduction of healthcare costs, the need for accurate and timely monitoring of intracranial pressure becomes increasingly critical. This demand is further fueled by advancements in technology, which have led to the development of innovative monitoring devices capable of providing real-time data and enhancing patient care.
In addition to demand drivers, the market dynamics of ICP monitoring are influenced by regulatory frameworks, reimbursement policies, and healthcare infrastructure. Regulatory approvals play a significant role in market penetration, as manufacturers must adhere to stringent quality standards and safety regulations to ensure the efficacy and reliability of their products. Moreover, reimbursement policies dictate the accessibility of ICP monitoring devices and procedures, impacting adoption rates across different regions. In markets where reimbursement is readily available, such as North America and Europe, adoption rates tend to be higher compared to regions with limited reimbursement schemes.
Furthermore, market dynamics are shaped by competitive forces, with numerous companies vying for market share through product innovation, strategic partnerships, and mergers and acquisitions. Established players in the ICP monitoring market leverage their technological expertise and brand recognition to maintain a competitive edge, while new entrants seek to disrupt the market with novel solutions and competitive pricing strategies. Strategic collaborations between device manufacturers and healthcare providers also play a pivotal role in driving market growth, as partnerships facilitate product development, clinical validation, and market access.
Moreover, the evolution of healthcare delivery models, such as the shift towards telemedicine and home-based care, presents both opportunities and challenges for the ICP monitoring market. Telemedicine platforms enable remote monitoring of patients' intracranial pressure levels, offering convenience and flexibility while reducing the burden on healthcare facilities. However, the widespread adoption of telemedicine necessitates the development of compatible monitoring devices and secure data transmission protocols to ensure patient safety and data integrity.
Despite the promising growth prospects, the ICP monitoring market faces certain constraints and uncertainties that may hinder its expansion. Economic volatility, healthcare budget constraints, and reimbursement cuts pose significant challenges for market players, affecting investment decisions and market expansion strategies. Moreover, concerns regarding patient privacy, data security, and regulatory compliance continue to be areas of focus, as stakeholders strive to address ethical and legal implications associated with the collection and transmission of sensitive health data.
Report Attribute/Metric | Details |
---|---|
Segment Outlook | Route of Intervention, Technique, Application, End User, and Region |
The Intra Cranial Pressure Monitor Market Size was valued at USD 2.16 Billion in 2023. The Global Intra Cranial Pressure Monitor industry is projected to grow from USD 2.27 Billion in 2024 to USD 4.01 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.78% during the forecast period (2024 - 2032). The market's growth is due to the growing prevalence of neurological disorders, the rapidly increasing geriatric population and technological improvements that enhance the market drivers driving the market.
The intracranial pressure (ICP) monitoring gadget Raumed Home ICP was introduced by Raumedic, a manufacturer of medical technology, in 2019. The product was created for individuals with hydrocephalus, a disorder where the brain accumulates excessive volumes of cerebrospinal fluid (CSF). The CE marking was recently applied to the device.
Technologically advanced ICP monitoring devices reduce the drawbacks of earlier invasive devices, including a spontaneous shift in baseline pressure and leveling and de-bubbling related to fluid-filled systems. For instance, medical robotics has witnessed a paradigm shift over the years owing to technological advancements in 3D imaging. Recent innovations include high-definition microscope cameras, data recorders, analytic data systems, motion sensors, remote navigation systems, and robotic-controlled catheters and transducers. Technological advancements aim to find new applications for existing platforms and create disruptive technologies that drive the market for intracranial pressure (ICP) monitoring devices. The invasive intracranial pressure monitor segment will rule the market CAGR.
Figure 1: Number of people aged more than 60 years around the globe
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
In addition, with the growing burden of neurodegenerative diseases such as dementia, Alzheimer's, Parkinson's, and others, along with the growing geriatric population who are more prone to head injuries and neurodegenerative diseases, the demand for intracranial pressure (ICP) monitoring is expected to increase which is anticipated to boost growth in the market for intracranial pressure (ICP) monitoring. For instance, according to the September 2021 report of the World Health Organization, about 55 million people worldwide are living with dementia, and nearly 10 million cases are reported yearly. Alzheimer's is the most typical form of dementia and constitutes around 60-70% of the total cases of dementia. According to the October 2021 update of the World Health Organization, the population of people of age 60 years and more is expected to increase from 1 billion in 2020 to 2.1 billion by 2050. These factors are collectively expected to significantly impact the studied market and propel the market growth of the intracranial pressure monitoring revenue globally.
The market segments of intracranial pressure monitoring, based on the intervention route, includes an intraventricular and epidural sensor. The intraventricular segment held the majority share in 2022 of intracranial pressure monitoring market data due to rapid technological advancements. However, the epidural sensor is the fastest-growing category over the forecast period due to growing incidences of diabetes among people.
The intracranial pressure (ICP) monitoring market segmentation, based on technique, includes invasive and non-invasive. The invasive segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2024-2032. This is owing to the fact that invasive ICP measurement can be performed at several intracranial anatomical locations. However, non-invasive is the fastest-growing category. This is due to invasive techniques associated with various complications such as infection, bleeding, malfunction, obstruction, and mispositioning of the catheter. Alternative non-invasive procedures for measuring elevated ICP are being sought due to the intrusive nature, high expense, and other extra dangers of current ICP monitoring methods.
Figure 2: Intracranial Pressure Monitoring Market, by Form, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The market segmentation of intracranial pressure monitoring, based on application, includes traumatic brain injury and subarachnoid hemorrhage. The traumatic brain injury segment dominated the intracranial pressure monitoring market revenue in 2022 and is projected to be the faster-growing category over the forecast period 2024-2032. Elevated ICP is the most common cause of death in patients suffering from traumatic brain injury. The success of treatment is largely based on the accurate assessment of ICP. Besides, technological advancements are anticipated to propel market growth in the coming years. However, subarachnoid hemorrhage is the fastest-growing category over the forecast period due to the strong association between elevated ICP and obesity, it can be anticipated that increasing obesity in the general population will increase the prevalence and socioeconomic disease burden.
The intracranial pressure monitoring market data, based on end users, includes hospitals, clinics, and trauma centers. The hospitals and clinics segment dominated the market revenue of intracranial pressure monitoring in 2023 and is projected to be the faster-growing category during the forecast period 2024-2032. This is attributed to hospitals' growing demand for intracranial pressure (ICP) monitoring systems. However, trauma is the fastest-growing category due to the growing usage of pressure (ICP) monitoring systems in traumatic centers.
By region, the study delivers market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America intracranial pressure monitoring market accounted for USD 1.145 billion in 2022, with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. This is anticipated due to the increasing availability of technologically advanced devices, growing demand for minimally invasive surgeries, and rising adoption of non-invasive ICP monitoring procedures. The market for intracranial pressure (ICP) monitoring devices is also expected to be driven by an increasing number of trauma cases and the rising incidence of migraine, stroke, and other neurological disorders.
Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: INTRACRANIAL PRESSURE MONITORING MARKET SHARE BY REGION 2023 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe intracranial pressure monitoring market accounts for the second-largest market share. The technological advancement in the devices used in intracranial pressure (ICP) monitoring intracranial pressure is expected to boost the market growth in this region. Moreover, UK market of intracranial pressure monitoring held the largest market share, and the Germany market of intracranial pressure monitoring was the fastest-growing market in the region.
The Asia Pacific intracranial pressure (ICP) monitoring market is expected to grow at the fastest CAGR from 2024 - 2032. The increasing incidence of sports injuries and trauma primarily drives the market. Emerging economies, such as China, Japan, South Korea, and India, are expected to witness considerable market growth over the forecast period. Further, the China market of intracranial pressure monitoring held the largest market share, and the India market of intracranial pressure monitoring was the fastest-growing market in the region.
Intracranial Pressure Monitoring Key Market Players & Competitive Insights
Key market players are spending a lot of money on R&D to enhance their product lines, which will assist the market of intracranial pressure monitoring to grow even more. Market participants are also taking several strategic initiatives to grow their worldwide footprint, with major market developments including new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the intracranial pressure (ICP) monitoring industry must offer cost-effective items to enhance and survive in an increasingly competitive and growing market environment.
One of the major business strategies adopted by manufacturers in the intracranial pressure (ICP) monitoring industry to benefit clients and enhance the market sector is to manufacture locally to decrease operating costs. The intracranial pressure (ICP) monitoring major market players such as Compumedics Limited (Australia), Natus Medical Incorporated (US), and others are working on enhancing the market demand by investing in R&D activities.
DePuy Synthes is a franchise of orthopedic and neurosurgery enterprises. Acquired by Johnson & Johnson in 1998, its firms form part of the Johnson & Johnson Medical Devices group. DePuy generates and markets products under the DePuy Mitek, Codman, DePuy Orthopaedics and DePuy Spine brands. In February 2021, DePuy Synthes collaborated with Expanding Innovations Inc. to distribute the X-Pac Expandable Lumbar Cage System in the U.S. It helped the company expand its presence there.
NovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system. NovaSignal was founded in 2013 with the sole mission of providing greater access to critical data needed by physicians to improve the lives of their patients. In February 2021, Novasignal Corporation released a cloud-based app to provide alarms to clinicians directly from its cerebral ultrasound gadget. The new app enables clinicians to receive immediate notifications from the Novaguide device, a transcranial Doppler ultrasound technology that combines robotics and artificial intelligence to provide real-time intracranial pressure (ICP) monitoring of blood flow in the brain (AI).
Key Companies in the market of intracranial pressure monitoring include
March 2021:Longeviti Neuro Solutions launched Longeviti ClearFit Cover, which replaces excised cranial bone following a neurosurgical procedure, enabling neurosurgeons to use ultrasound imaging to view neuroanatomy after brain surgery and allowing long-term intracranial pressure (ICP) monitoring of their patient's condition.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)